The protective effects of butorphanol tartrate against homocysteine-induced blood-brain barrier dysfunction

References

• Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14(1):6.
   PubMed Web of Science ®Google Scholar
• Givvimani S, Kundu S, Pushpakumar S, et al. Hyperhomocysteinemia: a missing link to dysfunctional HDL via paraoxanase-1. Can J Physiol Pharmacol. 2015;93(9):755–763.
   PubMed Web of Science ®Google Scholar
• Petras M, Tatarkova Z, Kovalska M, et al. Hyperhomocysteinemia as a risk factor for the neuronal system disorders. J Physiol Pharmacol. 2014;65(1):15–23.
   PubMed Web of Science ®Google Scholar
• Wu W, Guan Y, Xu K, et al. Plasma Homocysteine Levels Predict the Risk of Acute Cerebral Infarction in Patients with Carotid Artery Lesions. Mol Neurobiol. 2016;53(4):15–23.
   Web of Science ®Google Scholar
• Ma J, Chen Z, Chen S, et al. A prospective study on the association of plasma homocysteine level with stroke in hypertensive patients. Zhonghua Nei Ke Za Zhi. 2015;54(4):296–301.
   PubMedGoogle Scholar
• Kumar M, Sandhir R. Hydrogen sulfide attenuates hyperhomocysteinemia -induced blood-brain barrier permeability by inhibiting MMP-9. Int J Neurosci. 2021:1–11.
   Google Scholar
• Huang Y, Chen S, Luo Y, et al. Crosstalk between Inflammation and the BBB in Stroke. Curr Neuropharmacol. 2020;18(12):1227–1236.
   PubMed Web of Science ®Google Scholar
• Yang C, Hawkins KE, Dore S, et al. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol. 2019;316(2):C135–C53.
   PubMed Web of Science ®Google Scholar
• Jiang X, Andjelkovic AV, Zhu L, et al. Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol. 2018;163-164:144–171.
   PubMed Web of Science ®Google Scholar
• Lee H, Kim JM, Kim HJ, et al. Folic acid supplementation can reduce the endothelial damage in rat brain microvasculature due to hyperhomocysteinemia. J Nutr. 2005;135(3):544–548.
   PubMed Web of Science ®Google Scholar
• Beard RS Jr., Reynolds JJ, Bearden SE. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood. 2011;118(7):2007–2014.
   PubMed Web of Science ®Google Scholar
• Kamat PK, Kyles P, Kalani A, et al. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer’s Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder. Mol Neurobiol. 2016;53(4):2451–2467.
   PubMed Web of Science ®Google Scholar
• Li LM, Zheng B, Zhang RN, et al. Chinese medicine Tongxinluo increases tight junction protein levels by inducing KLF5 expression in microvascular endothelial cells. Cell Biochem Funct. 2015;33(4):226–234.
   PubMed Web of Science ®Google Scholar
• Cook TA. Butorphanol tartrate: an intravenous analgesic for outpatient surgery. Otolaryngol Head Neck Surg. 1983;91(3):251–254.
   PubMed Web of Science ®Google Scholar
• Chen FC, Shi XY, Li P, et al. Stability of butorphanol-tropisetron mixtures in 0.9% sodium chloride injection for patient-controlled analgesia use. Medicine (Baltimore). 2015;94(6):e432.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang JL, Ren HW, et al. Butorphanol protects on myocardial ischemia/reperfusion injury in rats through MAPK signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23:10541–10548.
   PubMed Web of Science ®Google Scholar
• Greene SA, Hartsfield SM, Tyner CL. Cardiovascular effects of butorphanol in halothane-anesthetized dogs. Am J Vet Res. 1990;51(8):1276–1279.
   PubMed Web of Science ®Google Scholar
• Chen WX, Wang HQ, Liu J, et al. Interference of KLF9 relieved the development of gestational diabetes mellitus by upregulating DDAH2. Bioengineered. 2022;13(1):395–406.
   PubMed Web of Science ®Google Scholar
• Cai ZX, Chen Y. Synergetic protective effect of berberine and ginsenoside Rb1 against tumor necrosis factor alpha−induced inflammation in adipocytes. Bioengineered. 2021;12(2):11784–11796.
   PubMed Web of Science ®Google Scholar
• Xing JH, Jia ZQ, Xu YC, et al. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells. Bioengineered. 2021;12(1):7563–7576.
   PubMed Web of Science ®Google Scholar
• Merkel SF, Andrews AM, Lutton EM, et al. Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells. J Neurochem. 2017;140(2):216–230.
   PubMed Web of Science ®Google Scholar
• Polo PA, Reis RO, Cedraz-Mercez PL, et al. Behavioral and neuropharmacological evidence that serotonin crosses the blood-brain barrier in Coturnix japonica (Galliformes; Aves). Braz J Biol. 2007;67(1):167–171.
   PubMedGoogle Scholar
• Phares TW, Fabis MJ, Brimer CM, et al. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J Immunol. 2007;178(11):7334–7343.
   PubMed Web of Science ®Google Scholar
• Kaya M, Ahishali B. Assessment of permeability in barrier type of endothelium in brain using tracers: evans blue, sodium fluorescein, and horseradish peroxidase. Methods Mol Biol. 2011;763:369–382.
   PubMedGoogle Scholar
• Tawfik A, Samra YA, and Elsherbiny NM, et al. Implication of Hyperhomocysteinemia in Blood Retinal Barrier (BRB) Dysfunction. Biomolecules. 2020;10(8):1119.
   Web of Science ®Google Scholar
• Li W, Yuan W, Zhang D, et al. LCZ696 Possesses a Protective Effect Against Homocysteine (Hcy)-Induced Impairment of Blood-Brain Barrier (BBB) Integrity by Increasing Occludin, Mediated by the Inhibition of Egr-1. Neurotox Res. 2021;39(6):1981–1990.
   PubMed Web of Science ®Google Scholar
• Abdullahi W, Tripathi D, Ronaldson PT. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol. 2018;315(3):C343–C56.
   PubMed Web of Science ®Google Scholar
• Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161(3):653–660.
   PubMed Web of Science ®Google Scholar
• Lee SW, Kim WJ, Choi YK, et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med. 2003;9(7):900–906.
   PubMed Web of Science ®Google Scholar
• Piontek J, Winkler L, Wolburg H, et al. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 2008;22(1):146–158.
   PubMed Web of Science ®Google Scholar
• Yang Y, Estrada EY, Thompson JF, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27(4):697–709.
   PubMed Web of Science ®Google Scholar
• Romanitan MO, Popescu BO, Winblad B, et al. Occludin is overexpressed in Alzheimer’s disease and vascular dementia. J Cell Mol Med. 2007;11(3):569–579.
   PubMed Web of Science ®Google Scholar
• Chen HL, Chong IW, Lee YC, et al. Kruppel‐like factor 5 mediates proinflammatory cytokine expression in lipopolysaccharide‐induced acute lung injury through upregulation of nuclear factor‐kappaB phosphorylation in vitro and in vivo. Mediators Inflamm. 2014;2014:281984.
   PubMed Web of Science ®Google Scholar
• Lappas M. KLF5 regulates infection-and inflammation‐induced pro‐labour mediators in human myometrium. Reproduction. 2015;149(5):413–424.
   PubMed Web of Science ®Google Scholar
• M‐l Z, Zheng B, Tong F, et al. iNOS‐derived peroxynitrite mediates high glucose‐induced inflammatory gene expression in vascular smooth muscle cells through promoting KLF5 expression and nitration. Biochim Biophys Acta Mol Basis Dis. 2017;1863(11):2821‐2834.
   Web of Science ®Google Scholar
• Li Y, Li J, Hou Z, et al. KLF5 overexpression attenuates cardiomyocyte inflammation induced by oxygen‐glucose deprivation/reperfusion through the PPARgamma/PGC‐1alpha/TNF‐alpha signaling pathway. Biomed Pharmacother. 2016;84:940‐946.
   Web of Science ®Google Scholar
• Li Y, Sui X, Hu X, et al. Overexpression of KLF5 inhibits puromycin‑induced apoptosis of podocytes. Mol Med Rep. 2018;18(4):3843–3849.
   PubMed Web of Science ®Google Scholar